Titilope Fasipe, MD, PhD: Advocacy for Rare Disease at the NORD Summit
Dr. Fasipe shares about her experience at the National Organization for Rare Disease Summit 2021 as the opening plenary speaker.
Read More
Virtual Reality is not a Viable Option for Reducing Pain During Hysteroscopy
Investigators found that using virtual reality to reduce pain levels during operational hsyteroscopy was not effective.
High sdLDL-C Levels Enhance Atherosclerotic Cardiovascular Disease Risk
A new study from the American Heart Association Scientific Sessions 2021 found that atherosclerotic cardiovascular disease risk increases with sdLDL-C levels, regardless of sex or race.
Understanding the Perception of Hydroxyurea in Sickle Cell Disease Treatment
Hydroxyurea has been on the market for decades and yet it's underutilized as a treatment for sickle cell disease.
FDA Approves Treatment for Rare Blood Disease Polycythemia Vera
Ropeginterferon Alfa-2b-NJFT (Besremi) is approved by the FDA for the treatment of polycythemia vera regardless of a patient's treatment history.
Guselkumab Alleviates Pain in Patients with Psoriatic Arthritis
Continual improvement was shown in patient-reported pain levels when treated with guselkumab compared with placebo.
Jean Liew, MD, MS, Discusses COVID-19 Vaccine Efficacy in Patients with Rheumatic Disease
Results show that antimetabolites and BCDT medications were frequently represented in the group of vaccinated patients who were hospitalized for COVID-19.
Mithu Maheswaranathan, MD: Improving Health Literacy in Patients with SLE
Interventions for patients with systemic lupus erythematosus (SLE) need to address physician/patient communication to improve health outcomes, according to Dr. Maheswaranathan.
Patient B-Cell Counts at Time of Vaccine Influence COVID-19 Antibody Response
Patients who are treated with B cell depletion therapies show that their B cell count at time of vaccination can impact their COVID-19 antibody response.
Jean Liew, MD, MS: SARS-COV-2 Infection in Vaccinated Rheumatic Disease Patients
Late-breaking data from ACR 2021 shows that most of the fully vaccinated patients with breakthrough infections of SARS-COV-2 were on anti-metabolites or BCDT.
Mithu Maheswaranathan, MD, Speaks About Low Health Literacy in SLE Patients
Lower health literacy has been found to be associated with worsened health outcomes for patients with systemic lupus erythematosus (SLE).
Jonathan Vela, MD: CBD Shows No Effect in Patients with Chronic Pain
A study presented at ACR 2021 found that CBD had no significant effect on pain intensity in patients with hand osteoarthritis or psoriatic arthritis.
Nathan den Broeder, MSs: Finding the Right Dose of Rituximab for Rheumatoid Arthritis
This study shows that many patients with rheumatoid arthritis can use a dose lower than 1000mg and still see results.
Jonathan Vela, MD, Decides it's Time to Examine CBD Treatment for Chronic Pain
With the popularity of CBD growing in Denmark, Jonathan Vela, MD, examined the effectiveness of CBD treatment on hand osteoarthritis and psoriatic arthritis.
Jing Cui, PhD, Discusses Next Steps for Risk Prediction Models for SLE
In this video interview, Dr. Jing Cui explains what the next steps could be for the risk prediction models of systemic lupus erythematosus.
Ehizogie Edigin, MD: Outpatient Care Helps Reduce Hospitalizations for SLE Flare
In this video interview, Dr. Edigin talks about the importance of outpatient care in reducing hospitalizations for SLE flare.
Nathan den Broeder, MSs: Treating Rheumatoid Arthritis with Lower Doses of Rituximab
Nathan den Broeder, MSs, shares the findings of his study at the ACR 2021 Convergence.
Jing Cui, PhD: Identifying Risk Factors for Systemic Lupus Erythematosus
Research presented by Dr. Jing Cui at ACR 2021 Convergence identified significant risk factors for systemic lupus erythematosus in a risk prediction model study.
Ehizogie Edigin, MD, Discusses Racial Disparities Found in SLE Study
Research results shows that while overall hospitalization for SLE flare decreased, it increased among African American patients.
Jing Cui, PhD: SLE Risk Assessment Among Nurse Cohorts
Dr. Jing Cui speaks about how she examined lifestyle and environmental factors as well as genetic risk to assess risk of systemic lupus erythematosus.
Ehizogie Edigin, MD: SLE Flare Hospitalizations Decreased Over 2 Decades
In this interview, Dr. Edigin speaks about his longitudinal trend analysis that showed a decrease in SLE flare hospitalizations over the last 20 years.
New Study Examines Cognitive Behavioral Therapy as Chronic Pain Treatment
The randomized control trial investigates the effectiveness of cognitive behavioral therapy in treating chronic pain in patients who have been using opioid therapy.
Titilope Fasipe, MD, PhD: Plenary Speaker at NORD Summit
As the opening plenary speaker at the National Organization for Rare Disease summit, Dr. Fasipe shares from her unique perspective as doctor and patient of sickle cell disease.
New Study Compares Safety Profile of mRNA Vaccines with Influenza Vaccines
This study looks at the risk of adverse events following immunization by comparing the safety profile of the mRNA COVID-19 vaccines to the safety profile of the influenza vaccines.
Study Finds Race Irrelevant in COVID-19 Vaccine Acceptance Among IBD Patients
Even though COVID-19 infection disproportionately impacts minority patients, there’s no indication that vaccine intention differs depending on race in IBD patients.
Examining the Prevalence of Celiac Disease in Patients with Type 1 Diabetes Mellitus
This study found that compared with the general population, the prevalence of celiac disease in people with type 1 diabetes mellitus is increased.
William Chey, MD, Explores Integrated Care for IBS Treatment at ACG 2021
In his lecture, The End of the Beginning: Megatrends in Gastroenterology, William Chey, MD, emphasizes the importance of a multidisciplinary integrated care approach to treating IBS.
Jessica R Allegretti, MD, MPH: Preventing Recurrent C Difficile with CP101
A new study presented at ACG 2021 shows microbiome therapeutic CP101 effective in preventing recurrent CDI by increasing intestinal microbiome diversity.
James Izanec, MD, AGAF: Examining Quality of Life in Crohn's Disease Treatment
Biologic therapies show promising results of clinical remission in patients with Crohn's disease.
Rawan Aljaras, MD: The Impact of Diet on Patients with Irritable Bowel Syndrome
Dr. Aljaras talks about the importance of focusing on diet when examining irritable bowel syndrome.